Merck

Merck is a major American multinational pharmaceutical company that develops, manufactures, and markets a wide range of medicines, vaccines, and animal health products.

Why it’s in the news: It is in the news due to recent setbacks for its cancer drug Keytruda, discontinuation of an antibiotic amid resistance concerns, and its involvement in the competitive vaccine market.

Latest on Merck

• STAT+: Merck suffers a setback in Europe over its new Keytruda formulation
• STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market
• STAT+: Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more
• AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows
• STAT+: Merck discontinues a crucial antibiotic despite concerns over superbug resistance
• STAT+: Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more
• 13F: Gerald Baker Financial Llc holds Merck ($2M)
• 13F: Intelligence Driven Advisers Llc holds Merck ($1M)
• 13F: Journey Retirement Planning & Investment Management Llc holds Merck ($1M)
• 13F: Kaydan Wealth Management holds Merck ($432,733)

Connections

59 entities linked to Merck across the news graph.